New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on: January 12,2024

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on:January 12,2024

Researchers identify drug characteristics that make cancer metastasis therapy more effective

by Tohoku UniversityOptimal osmotic pressure and viscosity ranges for anticancer drug solvents used in lymphatic delivery (blue area). It is applicable to all types of cancer. Credit: Tohoku Univ

Updated on: February 03,2024

Researchers identify drug characteristics that make cancer metastasis therapy more effective

by Tohoku UniversityOptimal osmotic pressure and viscosity ranges for anticancer drug solvents used in lymphatic delivery (blue area). It is applicable to all types of cancer. Credit: Tohoku Univ

Updated on:February 03,2024

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI

Updated on: March 01,2024

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI

Updated on:March 01,2024

Researchers test novel gene therapy for glioblastoma

by University Hospitals Cleveland Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and

Updated on: June 24,2024

Researchers test novel gene therapy for glioblastoma

by University Hospitals Cleveland Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and

Updated on:June 24,2024

Researchers find a 'critical need' for whole genome sequencing of young cancer patients

by St. Jude Children's Research HospitalSt. Jude investigators (from left) Michael Rusch, Sheila Shurtleff, Ph.D., Jinghui Zhang, Ph.D., and Scott Newman, Ph.D. Credit: St. Jude Children'

Updated on: June 22,2024

Researchers find a 'critical need' for whole genome sequencing of young cancer patients

by St. Jude Children's Research HospitalSt. Jude investigators (from left) Michael Rusch, Sheila Shurtleff, Ph.D., Jinghui Zhang, Ph.D., and Scott Newman, Ph.D. Credit: St. Jude Children'

Updated on:June 22,2024

Research quantifies effect of chronic diseases on racial disparity in COVID-associated hospitalizations

by Louisiana State UniversityCredit: CC0 Public DomainLSU Health New Orleans conducted the first research using disease surveillance data to quantify the effect of chronic diseases on racial disp

Updated on: June 28,2024

Research quantifies effect of chronic diseases on racial disparity in COVID-associated hospitalizations

by Louisiana State UniversityCredit: CC0 Public DomainLSU Health New Orleans conducted the first research using disease surveillance data to quantify the effect of chronic diseases on racial disp

Updated on:June 28,2024

The search to discover why 'outliers' survive deadliest cancers

by Isabelle TOURNÉThe biotech start-up Cure51 is working on the first global molecular database of exceptional survivors of cancer.When Herve found out he had glioblastoma—the most aggressive form of

Updated on: March 30,2024

The search to discover why 'outliers' survive deadliest cancers

by Isabelle TOURNÉThe biotech start-up Cure51 is working on the first global molecular database of exceptional survivors of cancer.When Herve found out he had glioblastoma—the most aggressive form of

Updated on:March 30,2024

Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.016Anti-cancer immune cells are critical to inhibiti

Updated on: February 18,2024

Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.016Anti-cancer immune cells are critical to inhibiti

Updated on:February 18,2024

Researchers circumvent radiation resistance in subtype of brain tumors

by University of MichiganMutant IDH1 glioma invading the normal brain structures. Non-tumor astrocytes are stained using an anti-GFAP antibody and are seen in brown. Credit: Maria Castro, Ph.D.It

Updated on: February 24,2024

Researchers circumvent radiation resistance in subtype of brain tumors

by University of MichiganMutant IDH1 glioma invading the normal brain structures. Non-tumor astrocytes are stained using an anti-GFAP antibody and are seen in brown. Credit: Maria Castro, Ph.D.It

Updated on:February 24,2024

Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

by The Spanish National Cancer Research CentreGraphical abstract. Credit:EMBO Molecular Medicine(2023). DOI: 10.15252/emmm.202216715The drug denosumab is currently used to treat osteo

Updated on: January 30,2024

Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

by The Spanish National Cancer Research CentreGraphical abstract. Credit:EMBO Molecular Medicine(2023). DOI: 10.15252/emmm.202216715The drug denosumab is currently used to treat osteo

Updated on:January 30,2024

Research points to an immunotherapy to overcome resistant leukemia

by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula

Updated on: March 30,2024

Research points to an immunotherapy to overcome resistant leukemia

by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula

Updated on:March 30,2024

Researchers shed light on signaling pathway responsible for head and neck cancers

by Gina DiGravio,Boston University School of MedicineCausal Inference Models of Interactions Between Pathways/Cell States in Head and Neck Cancer scRNAseq Data. A. Causal inference graphs indica

Updated on: February 18,2024

Researchers shed light on signaling pathway responsible for head and neck cancers

by Gina DiGravio,Boston University School of MedicineCausal Inference Models of Interactions Between Pathways/Cell States in Head and Neck Cancer scRNAseq Data. A. Causal inference graphs indica

Updated on:February 18,2024